Skip to main content
Clinical Trials/CTRI/2021/03/032028
CTRI/2021/03/032028
Completed
N/A

A pilot study to determine the T cell immune response in seriously ill COVID-19 subjects: A Pilot observational study in Pune, India - IRCO-19 Study

Dr D Y Patil Vidyapeeth Pune0 sites137 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B342- Coronavirus infection, unspecified
Sponsor
Dr D Y Patil Vidyapeeth Pune
Enrollment
137
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 15, 2023
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Dr D Y Patil Vidyapeeth Pune

Eligibility Criteria

Inclusion Criteria

  • Both male and female participants age of 18 years or greater from Pune region, and only who are laboratory confirmed by diagnostic Real\-time RT\-PCR test with the following features:
  • (1\) hospitalized requiring supplemental oxygen.
  • (2\) hospitalized requiring non\-invasive ventilation or the use of high\-flow oxygen devices.
  • (3\) hospitalized receiving invasive mechanical ventilation or extracorporeal membrane oxygenation.

Exclusion Criteria

  • Study participants with other respiratory infections and with underlying infections will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials